CARsgen Therapeutics completes enrollment in Phase II trial of Satri-cel for advanced gastric cancer

CARsgen Therapeutics Holdings Limited, a prominent player in the field of CAR T-cell therapies, has announced the successful completion of patient enrollment for its pivotal ... Read More